Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTG| |TAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCC
End
29219038/28728131 (Hg38)
Nearest miRNA
hsa-mir-10395/Upstream/8328777; hsa-let-7e/Downstream/6394569;
Upstream sequence
ACAGTGTATTTTCAAAGAATGTCAAATGTAGTATTTGTTTTTATTATTGATCAAAGGCAGCTGTAGCTTCCAATaataatggctaacatctaccgagtac
Downstream sequence
tgtgtgcgagacacccttctgcatgctttacctgaattaccttatttaatcttcaaaaaccatcccgtgagagaggaactattattatacccattttaca
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.